AS3MT and prostate adenocarcinoma: The results indicated low expression of AS3MT in PRAD tissue, but not detected in the normal tissue (Figure 13B); HPA050811 antibody was used for ISLR (Figure 13C), in PRAD, expression of ISLR was moderate the normal prostate tissue was low; HPA002791 antibody was used for analyzing the expression of S100A8, the expression of S100A8 was not detected in the normal prostate tissue, however, S100A8 expression was detected in PRAD (Figure 13D).